BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11826259)

  • 1. ADHD, growth deficits, and relationships to psychostimulant use.
    Joshi SV
    Pediatr Rev; 2002 Feb; 23(2):67-8; discussion 67-8. PubMed ID: 11826259
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroendocrine responses to methylphenidate and d-amphetamine: applications to attention-deficit disorder.
    Lurie S; O'Quinn A
    J Neuropsychiatry Clin Neurosci; 1991; 3(1):41-50. PubMed ID: 7580171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of risks associated with short- and long-term psychostimulant therapy for treatment of ADHD in children.
    Kociancic T; Reed MD; Findling RL
    Expert Opin Drug Saf; 2004 Mar; 3(2):93-100. PubMed ID: 15006715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications.
    Varley CK; Vincent J; Varley P; Calderon R
    Compr Psychiatry; 2001; 42(3):228-33. PubMed ID: 11349243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
    Kollins SH
    J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylphenidate-related growth impairment.
    Holtkamp K; Peters-Wallraf B; Wüller S; Pfäaffle R; Herpertz-Dahlmann B
    J Child Adolesc Psychopharmacol; 2002; 12(1):55-61. PubMed ID: 12014596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of imipramine in Tourette's syndrome and attention deficit disorder: case report.
    Dillon DC; Salzman IJ; Schulsinger DA
    J Clin Psychiatry; 1985 Aug; 46(8):348-9. PubMed ID: 2862138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADHD update: new data on the risks of medication.
    Harv Ment Health Lett; 2006 Oct; 23(4):3-5. PubMed ID: 17183739
    [No Abstract]   [Full Text] [Related]  

  • 9. Stimulant medication effects on growth and bone age in children with attention-deficit/hyperactivity disorder: a prospective cohort study.
    Poulton AS; Bui Q; Melzer E; Evans R
    Int Clin Psychopharmacol; 2016 Mar; 31(2):93-9. PubMed ID: 26544899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate: growth retardation.
    Prescrire Int; 2011 Oct; 20(120):238-9. PubMed ID: 21970086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attention deficit hyperactivity disorder in children.
    Ramchandani P; Joughin C; Zwi M
    Clin Evid; 2002 Dec; (8):280-90. PubMed ID: 12603883
    [No Abstract]   [Full Text] [Related]  

  • 12. An update on attention deficit disorder.
    Harv Ment Health Lett; 2004 May; 20(11):4-7. PubMed ID: 15153391
    [No Abstract]   [Full Text] [Related]  

  • 13. Daily methylphenidate use slows the growth of children: a community based study.
    Lisska MC; Rivkees SA
    J Pediatr Endocrinol Metab; 2003 Jun; 16(5):711-8. PubMed ID: 12880120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attention deficit hyperactivity disorder in children.
    Ramchandani P; Joughin C; Zwi M
    Clin Evid; 2002 Jun; (7):262-71. PubMed ID: 12230649
    [No Abstract]   [Full Text] [Related]  

  • 15. Stimulant medication withdrawal during long-term therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder.
    Nolan EE; Gadow KD; Sprafkin J
    Pediatrics; 1999 Apr; 103(4 Pt 1):730-7. PubMed ID: 10103294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk of psychosis with treatment for ADHD].
    Kooij JJS
    Ned Tijdschr Geneeskd; 2020 Aug; 164():. PubMed ID: 32940981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylphenidate and dextroamphetamine abuse in substance-abusing adolescents.
    Williams RJ; Goodale LA; Shay-Fiddler MA; Gloster SP; Chang SY
    Am J Addict; 2004; 13(4):381-9. PubMed ID: 15370936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The medical treatment of attention deficit hyperactivity disorder (ADHD) with amphetamines in children and adolescents].
    Frölich J; Banaschewski T; Spanagel R; Döpfner M; Lehmkuhl G
    Z Kinder Jugendpsychiatr Psychother; 2012 Sep; 40(5):287-99; quiz 299-300. PubMed ID: 22869222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylphenidate and dextroamphetamine-induced peripheral vasculopathy.
    Syed RH; Moore TL
    J Clin Rheumatol; 2008 Feb; 14(1):30-3. PubMed ID: 18431096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of attention-deficit-hyperactivity disorder.
    Elia J; Ambrosini PJ; Rapoport JL
    N Engl J Med; 1999 Mar; 340(10):780-8. PubMed ID: 10072414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.